Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis
- PMID: 8245985
- DOI: 10.1111/j.1471-4159.1993.tb07478.x
Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis
Abstract
The cause of neuronal death in amyotrophic lateral sclerosis (ALS) is unknown. Recently, it was found that some patients with autosomal-dominant familial ALS (FALS) have point mutations in the gene that encodes Cu/Zn superoxide dismutase (SOD1). In this study of postmortem brain tissue, we examined SOD activity and quantified protein carbonyl groups, a marker of oxidative damage, in samples of frontal cortex (Brodmann area 6) from 10 control patients, three FALS patients with known SOD1 mutations (FALS-1), one autosomal-dominant FALS patient with no identifiable SOD1 mutations (FALS-O), and 11 sporadic ALS (SALS) patients. Also, we determined the activities of components of the electron transport chain (complexes I, II-III, and IV) in these samples. The cytosolic SOD activity, which is primarily SOD1 activity, was reduced by 38.8% (p < 0.05) in the FALS-1 patients and not significantly altered in the SALS patients or the FALS-O patient relative to the control patients. The mitochondrial SOD activity, which is primarily SOD2 activity, was not significantly altered in the FALS-1, FALS-O, or SALS patients. The protein carbonyl content was elevated by 84.8% (p < 0.01) in the SALS patients relative to the control patients. Finally, the complex I activity was increased by 55.3% (p < 0.001) in the FALS-1 patients relative to the control patients. These results from cortical tissue demonstrate that SOD1 activity is reduced and complex I activity is increased in FALS-1 patients and that oxidative damage to proteins is increased in SALS patients.
Similar articles
-
Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis.J Neurochem. 1998 Jul;71(1):281-7. doi: 10.1046/j.1471-4159.1998.71010281.x. J Neurochem. 1998. PMID: 9648876
-
Evidence of increased oxidative damage in both sporadic and familial amyotrophic lateral sclerosis.J Neurochem. 1997 Nov;69(5):2064-74. doi: 10.1046/j.1471-4159.1997.69052064.x. J Neurochem. 1997. PMID: 9349552
-
Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis.J Neurochem. 1995 May;64(5):2366-9. doi: 10.1046/j.1471-4159.1995.64052366.x. J Neurochem. 1995. PMID: 7722523
-
[Familial amyotrophic lateral sclerosis and mutations in the Cu/Zn superoxide dismutase gene].Rinsho Shinkeigaku. 1995 Dec;35(12):1546-8. Rinsho Shinkeigaku. 1995. PMID: 8752459 Review. Japanese.
-
Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations: neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions.Histol Histopathol. 1999 Jul;14(3):973-89. doi: 10.14670/HH-14.973. Histol Histopathol. 1999. PMID: 10425565 Review.
Cited by
-
Mitochondria: A Promising Convergent Target for the Treatment of Amyotrophic Lateral Sclerosis.Cells. 2024 Jan 29;13(3):248. doi: 10.3390/cells13030248. Cells. 2024. PMID: 38334639 Free PMC article. Review.
-
Glucose Metabolic Dysfunction in Neurodegenerative Diseases-New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic Reprogramming.Int J Mol Sci. 2021 May 31;22(11):5887. doi: 10.3390/ijms22115887. Int J Mol Sci. 2021. PMID: 34072616 Free PMC article. Review.
-
Identification of TYW3/CRYZ and FGD4 as susceptibility genes for amyotrophic lateral sclerosis.Neurol Genet. 2019 Nov 8;5(6):e375. doi: 10.1212/NXG.0000000000000375. eCollection 2019 Dec. Neurol Genet. 2019. PMID: 31872054 Free PMC article.
-
Impaired Pentose Phosphate Pathway in the Spinal Cord of the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.Mol Neurobiol. 2019 Aug;56(8):5844-5855. doi: 10.1007/s12035-019-1485-6. Epub 2019 Jan 26. Mol Neurobiol. 2019. PMID: 30685842
-
Autoimmunity in amyotrophic lateral sclerosis: past and present.Neurol Res Int. 2011;2011:497080. doi: 10.1155/2011/497080. Epub 2011 Aug 1. Neurol Res Int. 2011. PMID: 21826267 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous
